# Chemotherapeutic Agents in Brain/Breast

> **NCT00795678** · — · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 10 (actual)

## Conditions studied

- Breast Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** lapatinib ditosylate
- **DRUG:** paclitaxel
- **DRUG:** vinorelbine ditartrate
- **DRUG:** Trastuzumab

## Key facts

- **NCT ID:** NCT00795678
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-08-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00795678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00795678, "Chemotherapeutic Agents in Brain/Breast". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00795678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*